(19)
(11) EP 2 922 841 A1

(12)

(43) Date of publication:
30.09.2015 Bulletin 2015/40

(21) Application number: 13795911.0

(22) Date of filing: 07.11.2013
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
C07D 413/14(2006.01)
C07D 417/14(2006.01)
A61K 31/444(2006.01)
A61P 37/00(2006.01)
 C07D 405/14(2006.01)
C07D 401/12(2006.01)
C07D 471/04(2006.01)
A61P 35/00(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/US2013/068842
(87) International publication number:
WO 2014/074660 (15.05.2014 Gazette 2014/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 08.11.2012 US 201261723854 P

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 08543 (US)

(72) Inventors:
  • MOSLIN, Ryan M.
    Princeton, New Jersey 08543 (US)
  • LIN, Shuqun
    Princeton, New Jersey 08543 (US)
  • WEINSTEIN, David S.
    Princeton, New Jersey 08543 (US)
  • WROBLESKI, Stephen T.
    Princeton, New Jersey 08543 (US)
  • ZHANG, Yanlei
    Princeton, New Jersey 08543 (US)
  • TOKARSKI, John S.
    Princeton, New Jersey 08543 (US)
  • MERTZMAN, Michael E
    Princeton, New Jersey 08543 (US)

(74) Representative: Reitstötter Kinzebach 
Patentanwälte Sternwartstrasse 4
81679 München
81679 München (DE)

   


(54) ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES